LncBase Predicted v.2
Help
Please cite:
Maria D. Paraskevopoulou, Ioannis S. Vlachos, Dimitra Karagkouni, Georgios Georgakilas, Ilias Kanellos, Thanasis Vergoulis, Konstantinos Zagganas, Panayiotis Tsanakas, Evangelos Floros, Theodore Dalamagas, and Artemis G. Hatzigeorgiou "DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts" Nucl. Acids Res. (2016) gkv1270
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link
Deprecated!
This version is deprecated. Users are strongly advised to only use the latest, up-to-date versions of DIANA-Tools and Databases.
Please follow this link to navigate to the latest database version.

hsa-miR-155-5p

ENST00000499521

or   Search by location
Loading... Please wait, this might take a few seconds...



Go to Experimental module
Filters

Gene
miRNA
Score
DIANA Links
CTB-89H12.4
hsa-miR-155-5p
0.799
mTTBlnEmP

Gene Details
Chromosome: 5
Transcript: ENST00000499521
Biotype: retained_intron
Gene id: ENSG00000230551
Gene Name: CTB-89H12.4
UCSC graphic:
Expression:
  Cell Line Tissue Category
K562 Blood Cancer/Malignant
GM12878 Blood Cancer/Malignant
HUVEC Blood Vessel Normal/Primary
hMSC-BM Bone Marrow Stem/Progenitor
SK-N-SH Brain Cancer/Malignant
HeLa Cervix Cancer/Malignant
h1ESC Embryonic Stem Cells Embryonic/Fetal/Stem/Progenitor
HREpiC Kidney Normal/Primary
HepG2 Liver Cancer/Malignant
A549 Lung Cancer/Malignant
IMR90 Lung Embryonic/Fetal/Stem/Progenitor
MCF7 Mammary Gland Cancer/Malignant
LCLBAC - Normal/Primary
LCLBACD2 - Normal/Primary
LCLBACD1 - Normal/Primary
LCLBACD3 - Normal/Primary


miRNA Details
Name: hsa-miR-155-5p
Sequence: uuaaugcuaaucgugauaggggu
MirBase ID: MIMAT0000646
Related Diseases:

Binding Category
Transcript Position
Binding Score
Conservation
8mer
1324-1335
0.016
3
7mer
1873-1892
0.013
10
6mer
1694-1717
0.004
12
Funded by:
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more
I accept